Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CBIO
MASS
Add up to 3 more stocks
CBIO
Crescent Biopharma, Inc.
+0.79%
$14.05+0.11Delayed quote: Oct 6, 2026, 2:35 PM EDT
Market Cap
$521.87M
52W Range
$8.72 - $27.41
MASS
908 Devices Inc.
-2.81%
$12.44-0.36Delayed quote: Oct 6, 2026, 2:34 PM EDT
Market Cap
$510.37M
52W Range
$5.03 - $13.33
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 3.28 | 4.03 |
| P/S Ratio | 43.92 | 8.39 |
| P/FCF Ratio | N/A | 1058.86 |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 100.0% | 49.8% |
| Operating Margin | -1407.5% | -46.0% |
| Net Margin | -1371.5% | -56.7% |
| ROE | -99.8% | -27.2% |
| ROA | -89.2% | -17.5% |
| ROIC | -102.6% | -18.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 9.66 | 2.67 |
| Quick Ratio | 9.66 | 2.38 |
| Debt/Equity | 0.01 | 0.03 |
| Interest Coverage | -69.85 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.